Ovarcoming

Welcome to OVEA!

Clinical Trials Matching For Ovarian Cancer Community

Interested in exploring clinical trial options for ovarian cancer?

Let us walk with you and assist you on your search.

Knowledge Empowers.
We are here to help you and your loved ones make informed decisions
and choices about your health care needs.

Research will ultimately cure ovarian cancer. Clinical trials are research studies via which researchers determine if a new form of treatment or prevention, such as a new drug, diet, or medical device is safe and effective. We invite you to explore the latest advancements and clinical trials in ovarian cancer. With the help of OVEA, be empowered to:

Know and learn about your options
Access the latest available treatments
Receive carefully guided and monitored world class care

Let’s discover the power of clinical trials
as we Ovarcome together!

This video is intended to provide a basic overview of the biological mechanisms behind ovarian cancer and its treatment and is for informational purposes only. It is not intended to provide medical guidance related to diagnosis, treatment, or related topics. We are grateful to our Advisory Board Member Dr. Anirban Maitra for verifying the scientific accuracy of all the information presented.

I am OVEA, and I look forward to helping you find your match!

Please watch the following videos to learn more about clinical trials and to optimize your search.

You may also read the FAQs here

Note: Please click on the ClinicalTrials.gov Identifier number for additional information
on any trial on the clinicaltrials.gov website

Featured Clinical Trials

Explore the latest in ovarian cancer research studies

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

This phase I/IIa trial studies the side effects and best dose of a type of specialized immune cell (natural killer cell-like cytotoxic T-lymphocytes (CTLs) (nCTLs) and how well they work when given wi...

LEARN MORE

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wear...

LEARN MORE

Assessing the Time Demands of Cancer

A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry t...

LEARN MORE

Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer

This phase I/II trial tests the safety, side effects and best dose of a combination therapy (niraparib and selenium) in treating patients with BRCA negative ovarian cancer that has come back (recurren...

LEARN MORE

Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer

The purpose of this study is to find out if a new drug, M4344, is safe and has beneficial effects when given in combination with the PARP inhibitor, Niraparib, in women with recurrent ovarian cancer t...

LEARN MORE

Hello, my name is Kristin Johnson, and I am your Clinical Trials Navigator. I have been an oncology nurse for 15 years. I have a BS in Genetics from Texas A&M University, a BS in Nursing from the University of Texas Health Science Center, and an MSN in Nursing Administration from UT Arlington. My oncology nursing experience has been at MD Anderson Cancer Center in the Gynecologic Oncology Department, in both inpatient and outpatient roles. My most recent role was as a Clinical Research Nurse. I have been involved as a volunteer with Ovarcome for many years. My mom Betty White is on the board and is a 25-year survivor of ovarian cancer. I look forward to answering questions and helping patients and caregivers gather information about ovarian cancer clinical trials.

Via OvarCare Counseling we are pleased to offer: Up to 6 sessions of support for up to 6 months Meetings by phone in any location in the U.S. Supportive services to OvarCare grant recipients Information, resources, referrals as needed and requested Our OvarCare counseling sessions are designed to provide support through the journey of Ovarcoming Ovarian Cancer and are not deemed to be psychotherapy services. Our members are ready to provide compassionate and meaningful support via active listening, providing gentle guidance in navigating the often-challenging course of diagnosis, treatment and survivorship, and in providing effective tools and resources to Ovarcome. Please complete the fields below to register for our counseling program: We are here to Ovarcome with you. Welcome to our safe and friendly space. This is a complimentary service as part of our OvarCare Program and is currently available in English only.
Information
Name: *
Date of birth: *
Email Address: *
Address: *
Do you consent to receiving text messages from your OvarCare Support Services?: *	YesNo
Share with us the best way to reach you: *	EmailPhoneText MessageAll of the above
Primary Phone Type: *	MobileLandline
Please indicate your time zone: *	Eastern TimeCentral TimeMountain TimePacific Time Hawaii-Aleutian Time
What do you wish to accomplish from these support sessions? Please share your personal goal: *
Please carefully review the acknowledgements below: 1. OvarCare support services are designed to provide emotional and informational support and is not intended to provide any medical guidance. It is also not intended to provide psychotherapy, crisis management critical mental health issues2. You will be offered up to 6 counseling sessions for up to 6 months as part of this program. You will be contacted via the information you provide to us. Ovarcome is not responsible to maintain privacy of information if provided outside of the channels indicated on the form3. You agree to indemnify, defend, release and hold harmless Ovarcome, their employees, officers, directors, agents, successors and assigns, against all liabilities, claims, causes of action, damages, judgments, costs or expenses, including attorney's fees, caused by, resulting from or which arise in connection with your participation in OvarCare Support Services Program
Acknowledgement of My Consent BY CHECKING THIS CONSENT, I CERTIFY THAT: I have carefully read and consent to the terms and conditions stated herein.
Name: *
Date: *

Welcome to OVEA!

Clinical Trials Matching For Ovarian Cancer Community

Let’s discover the power of clinical trials as we Ovarcome together!

Featured Clinical Trials

Have a question? Let us know

Our Clinical Trials Program FInder is made possible by

Scan to Donate

We Need Your Help

Signup For Our Newsletter

Let’s discover the power of clinical trials
as we Ovarcome together!